Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues

Completed

• Conditions: Diabetes; Diabetes Mellitus, Type 2
• Interventions: Other: No treatment given

• Registration Number: NCT01585506
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

This study is conducted in Europe. The aim of this study is to investigate psychosocial factors related to compliance with treatment with biphasic insulin analogues.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09-20
• Primary Completion: 2010-12-20
• Study Completion: 2010-12-20
• Study First Submitted: 2012-03-26
• Study First Submitted QC: 2012-04-23
• Study First Posted: 2012-04-26
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-06
• Last Update Posted: 2018-02-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3618

Inclusion Criteria

• Patients with type 2 diabetes in whom therapy with biphasic insulin analogues was started

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Questionnaire responders	No treatment given	-

Primary Outcome Measures

Name	Time	Method
Frequency and level of difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins	Up to 3 months

Secondary Outcome Measures

Name	Time	Method
Correlations between the difficulty in introducing changes in compliance with the guidelines for biphasic insulin analogue use in subjects previously treated with biphasic human insulins, and psychosocial factors	Up to 3 months

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇵🇱 Warszawa, Poland